KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,909 | +632.7% | 10,807 | +1840.2% | 0.00% | – |
| Q1 2021 | $15,000 | -59.5% | 557 | -75.5% | 0.00% | – |
| Q4 2020 | $37,000 | +311.1% | 2,269 | +259.6% | 0.00% | – |
| Q3 2020 | $9,000 | -30.8% | 631 | -41.6% | 0.00% | – |
| Q2 2020 | $13,000 | -53.6% | 1,081 | -31.5% | 0.00% | – |
| Q4 2019 | $28,000 | +133.3% | 1,579 | +54.5% | 0.00% | – |
| Q3 2019 | $12,000 | -45.5% | 1,022 | +4.9% | 0.00% | – |
| Q2 2019 | $22,000 | -86.7% | 974 | -83.3% | 0.00% | – |
| Q1 2019 | $166,000 | +84.4% | 5,824 | +28.5% | 0.00% | – |
| Q4 2018 | $90,000 | – | 4,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |